Study gut microbiome differences in people with spondyloarthritis
Part of Bones, joints & muscles clinical trials.
This study looks at whether changes in the gut bacteria (called microbiome dysbiosis) are linked to spondyloarthritis. It compares people with the condition to people without it who are already planning a digestive scope for another reason.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or the patient) are 18 years or older
- If you have the condition: you have been diagnosed with spondyloarthritis using ASAS classification
- If you do not have the condition: you do not have spondyloarthritis and are scheduled for a digestive endoscopy for another reason
- You must have health coverage under the French social security system and sign consent
- You cannot be pregnant or breastfeeding
- You should not have taken antibiotics in the last month
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares the gut microbiome (the bacteria in your intestines) in adults with spondyloarthritis or rheumatoid arthritis versus healthy adults. It aims to better describe differences that may help explain these diseases.
This study looks at how a body signal called IL-23 may drive inflammation in spondyloarthritis (including joints) using samples from your care. It may help researchers identify which body cells and targets are involved, and how treatments could work better for active disease.
This study looks at stool (poop) samples to see whether gut bacteria patterns can help identify certain inflammatory arthritis conditions in people who have Crohn’s disease or axial spondyloarthritis. It’s mainly about matching stool “biomarkers” to diagnoses, which may help doctors recognize these conditions more accurately in the future.
This study looks at your gut bacteria (from a stool sample) to see whether it can predict how well you will respond to biologic medicines for spondyloarthritis. It may help doctors choose the most effective treatment for future patients.
This study follows people who were recently diagnosed with spondyloarthritis (a type of arthritis) to see how their symptoms change over time. It helps doctors understand the early stages of the disease better.
This trial tests whether transplanting healthy stool bacteria (fecal microbiota transplantation) can reduce symptoms in people with axial spondyloarthritis (including ankylosing spondylitis) who are not improving enough with standard medicines. If you qualify, you may receive study capsules containing processed bacteria and be closely monitored for safety and symptom changes.
Hear when a new Spondyloarthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.